As Boston Scientific Corp (BSX) Stock Price Rose, Jana Partners LLC Has Decreased Its Holding

Boston Scientific Corporation (NYSE:BSX) LogoInvestors sentiment increased to 1.2 in 2018 Q2. Its up 0.24, from 0.96 in 2018Q1. It is positive, as 38 investors sold BSX shares while 177 reduced holdings. 92 funds opened positions while 167 raised stakes. 1.21 billion shares or 2.60% more from 1.18 billion shares in 2018Q1 were reported. Hartford Invest owns 184,279 shares or 0.19% of their US portfolio. Nomura Asset Mngmt Ltd invested 0.18% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Northern Tru Corporation invested 0.12% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Endurant Cap Mngmt Limited Partnership reported 72,841 shares. Eaton Vance Mngmt owns 0.45% invested in Boston Scientific Corporation (NYSE:BSX) for 5.71 million shares. Moreover, Blair William Company Il has 0.01% invested in Boston Scientific Corporation (NYSE:BSX) for 29,306 shares. Amp Investors has 516,769 shares for 0.09% of their portfolio. Montag A And Assoc has 0.15% invested in Boston Scientific Corporation (NYSE:BSX) for 45,227 shares. Louisiana State Employees Retirement Systems reported 0.12% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Moreover, Highland Cap Management Limited Liability Company has 0.05% invested in Boston Scientific Corporation (NYSE:BSX) for 21,178 shares. Tci Wealth holds 0.03% in Boston Scientific Corporation (NYSE:BSX) or 2,260 shares. 44.36 million were reported by Jpmorgan Chase Company. The California-based Partner Fund Mngmt LP has invested 0.67% in Boston Scientific Corporation (NYSE:BSX). Thrivent Fincl For Lutherans stated it has 216,056 shares. The New York-based Element Cap Mgmt Limited Liability Company has invested 0.01% in Boston Scientific Corporation (NYSE:BSX).

Since June 7, 2018, it had 0 insider buys, and 20 selling transactions for $20.51 million activity. Carruthers Wendy sold 1,500 shares worth $54,965. Shares for $630,703 were sold by Mirviss Jeffrey B. on Thursday, June 14. Wang Xin Warren also sold $358,595 worth of Boston Scientific Corporation (NYSE:BSX) shares. Mahoney Michael F sold $4.53M worth of Boston Scientific Corporation (NYSE:BSX) on Monday, October 1. Another trade for 10,000 shares valued at $358,607 was made by Sorenson John Bradley on Monday, September 10. Thepaut Eric Francis Yves had sold 23,458 shares worth $879,886 on Friday, November 9.

Jana Partners Llc decreased its stake in Boston Scientific Corp (BSX) by 33.59% based on its latest 2018Q2 regulatory filing with the SEC. Jana Partners Llc sold 1.59M shares as the company’s stock rose 14.84% with the market. The hedge fund held 3.14M shares of the medical and dental instruments company at the end of 2018Q2, valued at $102.60 million, down from 4.72M at the end of the previous reported quarter. Jana Partners Llc who had been investing in Boston Scientific Corp for a number of months, seems to be less bullish one the $49.10 billion market cap company. The stock decreased 3.51% or $1.29 during the last trading session, reaching $35.48. About 7.40M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 25.61% since December 8, 2017 and is uptrending. It has outperformed by 9.99% the S&P500.

Jana Partners Llc, which manages about $11.37B and $3.78 billion US Long portfolio, upped its stake in Electronic Arts Inc (NASDAQ:EA) by 54,190 shares to 623,172 shares, valued at $87.88M in 2018Q2, according to the filing. It also increased its holding in Tiffany & Co New (NYSE:TIF) by 1.69 million shares in the quarter, for a total of 1.76M shares, and has risen its stake in First Data Corp New.

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on February, 7. They expect $0.37 EPS, up 8.82 % or $0.03 from last year’s $0.34 per share. BSX’s profit will be $512.00M for 23.97 P/E if the $0.37 EPS becomes a reality. After $0.35 actual EPS reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts 5.71 % EPS growth.

More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: Benzinga.com which released: “Jim Cramer Gives His Opinion On Boston Scientific, MongoDB And More – Benzinga” on November 28, 2018, also 247Wallst.com with their article: “Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, CME, DaVita, Skyworks, Spirit Air, AMD, Nvidia and More – 24/7 Wall St.” published on November 28, 2018, Benzinga.com published: “26 Stocks Moving In Tuesday’s Pre-Market Session – Benzinga” on November 20, 2018. More interesting news about Boston Scientific Corporation (NYSE:BSX) were released by: Forbes.com and their article: “MedSurg Will Likely Drive Boston Scientific’s Near-Term Earnings Growth – Forbes” published on November 29, 2018 as well as Seekingalpha.com‘s news article titled: “Medtronic slips 2% premarket on device injuries – Seeking Alpha” with publication date: November 26, 2018.

Boston Scientific Corporation (NYSE:BSX) Ratings Coverage

Among 10 analysts covering Boston Scientific Corp (NYSE:BSX), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Boston Scientific Corp had 11 analyst reports since June 12, 2018 according to SRatingsIntel. The firm earned “Overweight” rating on Thursday, July 26 by Morgan Stanley. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by Jefferies on Tuesday, September 4. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Outperform” rating by Wells Fargo on Monday, September 17. The firm has “Buy” rating given on Thursday, October 25 by Canaccord Genuity. The firm has “Strong Buy” rating by Raymond James given on Tuesday, September 4. The firm has “Overweight” rating by Morgan Stanley given on Tuesday, October 2. Argus Research maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, October 26. Argus Research has “Buy” rating and $43 target.

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.